Professor Antonio Giuliano

DVM,MS,GpCert(SAM),PgCert(CT),ECVIM (onc),MRCVS
European, RCVS and HK specialist in Companion Animals (Oncology)

Clinical Associate Professor

Office: Room 306, 3/F, Block 1A, To Yuen Building
Tel. no.: +852 3442-7257
Email: agiulian@cityu.edu.hk
Web: CityU Scholars

Biography

Prof. Antonio Giuliano graduated from the University of Messina in 2007. While working in general practice, he completed a master's degree in Small Animal Oncology from the University of Pisa, a post graduate certificate in cancer therapeutic at Barts Cancer Institute and the GpCert (SAM) in internal medicine.

He completed a rotating internship in a busy referral practice in UK and an oncology internship and residency at the Queen Veterinary School Teaching Hospital (QVSH), at the University of Cambridge.

After successfully completing the residency, he worked for one year as oncology clinician and supervisor at the QVSH. In the 2019 he moved to Hong Kong (HK) working as oncologist at CityU VMC, the largest multidisciplinary referral Hospital in HK.

Prof Antonio Giuliano is a recognised European, RCVS and HK specialist in Companion Animals (Oncology).

He published numerous articles in international peer reviewed journals and presented his research in many international conferences.

He has a broad interest in cancer research, with particular focus on finding new drugs/therapeutic approaches to improve survival time and quality of life of pets. He is also interested in preclinical and clinical investigations into the development of rapid tests to predict prognosis and/or early diagnosis of cancer.

Selected Publication

• Mosca A, Gibson D, Mason SL, Dobson J, Giuliano A. (2021). A possible role of coarse fractionated radiotherapy in the management of gingival squamous cell carcinoma in dogs: a retrospective study of 21 cases from two referral centres in the UK. J Vet Med Sci. DOI: 10.1292/jvms.20-0191


• Giuliano, A., & Dobson, J. (2020). Clinical response and survival time of cats with carcinoma of the nasal cavity treated with palliative coarse fractionated radiotherapy. Journal of Feline Medicine and Surgery. DOI: 10.1177/1098612X19893445


• Giuliano A., Dobson J. (2020) Prospective clinical trial of masitinib mesylate treatment for advanced stage III and IV canine malignant melanoma. J Smal Anim Pract, 61,3. DOI: 10.1111/jsap.13111


• Giuliano, A. , Watson, P. , Owen, L. , Skelly, B. , Davison, L. , Dobson, J. and Costantino-Casas, F. (2018), Idiopathic sterile pyogranuloma in three domestic cats. J Small Anim Pract. DOI: 10.1111/jsap.12853


• Horta, R.d., Giuliano, A., Lavalle, G.E., Costa, M.d., de Araujo, R.B., Constantino Casas, F., & Dobson, J.M. 2018. Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high risk canine mast cell tumours to tyrosine kinase inhibitors. Oncology Letters, 0, 0-0. DOI: 10.3892/ol.2017.7323


• Giuliano, A., dos Santos Horta, R., Constantino-Casas, F., Hoather, T. and Dobson, J., 2017. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours. Journal of comparative pathology, 156(1), pp.14-20. DOI: 10.1016/j.jcpa.2016.10.004


• Giuliano, A., Swift, R., Arthurs, C., Marote, G., Abramo, F., McKay, J., Thomson, C., Beltran, M., Millar, M., Priestnall, S. and Dobson, J.,et al., 2016. Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma. PloS one, 11(8), p.e0161103. DOI: 10.1371/journal.pone.0163838